BioCryst Pharmaceuticals

Ebit Veränderung Datum
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Gilead Sciences USD 2.15B 475M 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Ionis Pharmaceuticals USD -6123000 137.14M 2023-12
Regeneron Pharmaceuticals USD 1B 208.1M 2023-12
Roche Holding CHF 10.6B 2.12B 2023-06
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



BioCryst Pharmaceuticals - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2024.